Concepedia

Publication | Open Access

Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly

DOIFull Paper Access

14

Citations

21

References

2019

Year

Sharon E. Frey, Sepehr Shakib, Pornthep Chanthavanich, Peter Richmond, Timothy R. Smith, Terapong Tantawichien, Claudia Kittel, Peter Jaehnig, Zenaida Reynoso Mojares, Bikash Verma,
Open Forum Infectious Diseases

Abstract

In adult and elderly participants, the full-dose aH5N1c vaccine formulation was well tolerated and met US and European licensure criteria for pandemic vaccines.

References

YearCitations

Page 1